New Potomac Partners’s Zimmer Biomet ZBH Stock Holding History

New Potomac Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-124	Closed	-$16K	–	124
2020 Q3	$16K	Hold	124	–	–	0.01%	111
2020 Q2	$14K	Hold	124	–	–	0.01%	116
2020 Q1	$12K	Hold	124	–	–	0.01%	116
2019 Q4	$18K	Hold	124	–	–	0.02%	119
2019 Q3	$16K	Hold	124	–	–	0.02%	123
2019 Q2	$14K	Hold	124	–	–	0.01%	124
2019 Q1	$15K	Hold	124	–	–	0.02%	123
2018 Q4	$12K	Hold	124	–	–	0.01%	137
2018 Q3	$16K	Hold	124	–	–	0.01%	130
2018 Q2	$13K	Hold	124	–	–	0.01%	129
2018 Q1	$13K	Hold	124	–	–	0.01%	131
2017 Q4	$14K	Buy	+124	New	+$14K	0.01%	129

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

New Potomac Partners's ZBH Position: Q4 2020 in Review

New Potomac Partners sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 124 shares — an estimated $16K sold.

New Potomac Partners first reported a position in ZBH in Q4 2017 and held it in 12 quarters. The position peaked at $18K in Q4 2019. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

New Potomac Partners reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
New Potomac Partners sold 124 Zimmer Biomet shares in Q4 2020, an estimated $16K.
New Potomac Partners first reported a position in Zimmer Biomet in Q4 2017 and held it in 12 quarters.
New Potomac Partners's Zimmer Biomet position peaked at $18K in Q4 2019.
1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on New Potomac Partners's 13F filing for Q4 2020, filed 28 Jan 2021.